NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

A Study to Monitor Safety and Effectiveness of Approved J&J MedTech Devices in the Treatment of Participants With Ischemic Stroke

NCT07760649

Not Yet RecruitingN/A

Sponsor: Neuravi Limited

Conditions: Ischemic Stroke

Countries: Germany, Switzerland

The purpose of this study is to collect medical information to monitor the ongoing safety of the J\&J MedTech devices and to understand how well they work when routinely used to treat participants with acute ischemic stroke (a condition caused by a blocked blood vessel in the brain).

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion criteria:

* Participant is 18 years of age or older at the time of consent
* Informed Consent has been provided by the participant or the participants' legally authorized representative (LAR)
* Participants with angiographic confirmation of acute ischemic stroke
* A clinical decision has been made to treat the participant with an eligible Johnson \& Johnson MedTech neuro-thrombectomy device independently and prior to enrollment in the study

Exclusion criteria:

* Known pregnancy, as evidenced by positive pregnancy test for women of childbearing potential or breast feeding
* Current involvement in an investigational (drug, device, etcetera) clinical study that may confound study endpoints. Sponsor approval is required prior to enrollment

Locations (3)

Hamburg, Germany
Solingen, Germany
Zurich, Switzerland